Paper & Presentations [RSABE / ABEL]

posted by Helmut Homepage – Vienna, Austria, 2018-03-30 03:33 (1893 d 12:39 ago) – Posting: # 18622
Views: 9,055

Hi John,

❝ If I recall (or I am imagining things), FDA published a paper about NTI drug BE assessment (Helmut, help! Am I hallucinating again?)


[image]Too much absinthe? I guess you mean this goody:

Yu LX, Jiang W, Zhang X, Lionberger R, Makhlouf F, Schuirmann DF, Muldowney L, Chen M-L, Davit B, Conner D, Woodcock J. Novel Bioequivalence Approach for Narrow Thera­peutic Index Drugs. Clin Pharmacol Ther. 2015;97(3):286–91. doi:10.1002/cpt.28.


❝ Anyhow, Have you looked at this FDA slide presentation before?

NTI


Yep. There are others with more background information. Most simulations were performed in R – Donald told me in 2016 that he grew up with APL and finds R difficult… See also this post. The presentations are gone with the wind. Webarchive [image] #1 (June 2017), [image] #2 (July 2017). In #1 navigate to page 51 and in #2 to page 57.

Dif-tor heh smusma 🖖🏼 Довге життя Україна! [image]
Helmut Schütz
[image]

The quality of responses received is directly proportional to the quality of the question asked. 🚮
Science Quotes

Complete thread:

UA Flag
Activity
 Admin contact
22,616 posts in 4,740 threads, 1,614 registered users;
28 visitors (0 registered, 28 guests [including 15 identified bots]).
Forum time: 16:13 CEST (Europe/Vienna)

Mediocrity is a fungus of the mind.    Reif Larsen

The Bioequivalence and Bioavailability Forum is hosted by
BEBAC Ing. Helmut Schütz
HTML5